The increased infiltration of CD4+ TILs was associated with better prognosis of patients with esophageal squamous cell carcinoma (Chen et al., 2017) and triple-negative breast cancer (Gao et al., 2020). The gene discussed is CD4; the disease is triple-negative breast carcinoma.